Management of Diabetic Retinopathy
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
Changing Approach to Diabetic Retinopathy Management In 2015, there were 415 million people worldwide living with diabetes. Of those, 145 million had diabetic retinopathy (DR), and roughly one-third of those had severe vision loss, according to the International Diabetes Federation. By 2040, experts estimate 224 million people will have some form of DR and 70 million will have vision-threatening DR. Study results now indicate that early diagnosis and referral to a retina specialist for treatment of DR can help slow the disease progression. Patients must be educated about the importance of regular examinations because microvascular damage is often present even in patients without overt disease. This activity will focus on the importance of early and timely referral of patients with DR to retina specialists and understanding how DR may affect patients with cataracts.This educational activity is supported by a medical educational grant from Regeneron Pharmaceuticals and Carl Zeiss Meditec. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!










